Detalles de la búsqueda
1.
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition.
Front Immunol
; 13: 869676, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35572601
2.
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway.
Front Cell Dev Biol
; 10: 1022191, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36619857
3.
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models.
Front Oncol
; 12: 818437, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35530312
4.
Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells.
Cancers (Basel)
; 13(5)2021 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33668151
5.
Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade.
Cancer Drug Resist
; 3(4): 832-853, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582229
6.
AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer.
iScience
; 23(11): 101649, 2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33103086
7.
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells.
J Thorac Oncol
; 15(6): 973-999, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32018052
8.
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.
Cancer Metab
; 7: 6, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164982
Resultados
1 -
8
de 8
1
Próxima >
>>